Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$979,934
-$461,345 QoQ
Shares Held
817
-47.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#3,163
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Centerpoint Advisors, LLC holds $2,533,470 across 10 Drug Manufacturers - General names. LLY ranks #2 (38.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,965 | $1,006,991 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
817 | $979,934 | |
| 3 | ABBV |
AbbVie Inc.
|
1,182 | $297,438 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,035 | $132,997 | |
| 5 | PFE |
Pfizer Inc
|
3,152 | $75,900 | |
| 6 | BIIB |
Biogen Inc.
|
83 | $17,932 | |
| 7 | AMGN |
Amgen Inc
|
28 | $10,139 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
56 | $7,075 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $979,934 | 817 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,441,279 | 1,567 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,684,023 | 1,567 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,204,777 | 1,579 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,173,192 | 1,505 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,242,994 | 1,505 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,318,576 | 1,708 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,956,155 | 2,208 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,118,128 | 3,444 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,666,846 | 3,428 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $2,001,164 | 3,433 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $2,023,905 | 3,768 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,979,564 | 4,221 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $1,515,512 | 4,413 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,498,114 | 4,095 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,272,382 | 3,935 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $246,414 | 760 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $217,641 | 760 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $209,927 | 760 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $200,320 | 867 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $198,993 | 867 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $161,972 | 867 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $146,384 | 867 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $128,333 | 867 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $142,344 | 867 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $129,287 | 932 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||